Right ventricular function among adult survivors of childhood cancer
Background Cardiotoxic effects of childhood cancer treatment on the right ventricle (RV) are sparsely studied among long-term childhood cancer survivors (CCS). We investigated RV function and factors associated with impaired function. Methods We invited CCS ≥18 years of age, diagnosed between ages 0 and 20 years, treated in one of five paediatric oncology centres across Switzerland from 1976 to 2017, who survived ≥5 years, for an echocardiographic assessment of the RV including tricuspid annular plane systolic excursion (TAPSE, abnormal <17 mm) and Doppler tissue imaging (DTI, abnormal <9.5 cm/s). Results We included 432 CCS with mean age at study of 34 years. Overall prevalence of RV dysfunction was 4% by each measure. RV dysfunction was most frequent in survivors exposed to heart-relevant radiotherapy alone (13% by TAPSE; 9% by DTI). Heart-relevant radiotherapy dose, haematopoietic stem cell transplantation, cisplatin, diabetes mellitus and abdominal obesity were associated with lower TAPSE. Heart-relevant radiotherapy dose, relapse and abdominal obesity were associated with lower DTI. Cumulative anthracycline dose was not clearly associated with either measure although small effects cannot be excluded. Conclusions RV dysfunction was uncommon but was more frequent among survivors exposed to heart-relevant radiotherapy and among those with selected cardiovascular risk factors. These findings support further longitudinal evaluation of RV function in CCS.
Authors
- Claudia Elisabeth Kuehni (ORCID: https://orcid.org/0000-0001-8957-2002)
- Gabriela M. Kuster (ORCID: https://orcid.org/0000-0002-8209-4631)
- Nana Kwabena Poku (ORCID: https://orcid.org/0009-0004-9911-2658)
- Eva Scheler (ORCID: https://orcid.org/0009-0006-0674-7561)
- Nicolas von der Weid (ORCID: https://orcid.org/0000-0002-9555-3817)
- Tomáš Sláma (ORCID: https://orcid.org/0000-0002-4422-479X)
- Reto Kurmann (ORCID: https://orcid.org/0000-0002-6273-0880)
- Eva Haegler‐Laube (ORCID: https://orcid.org/0000-0003-0745-5035)
- Christina Schindera (ORCID: https://orcid.org/0000-0002-4511-287X)
Institutions
- University of Bern (CH)
- University of St.Gallen (CH)
- Kantonsspital St. Gallen (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- University Hospital of Geneva (CH)
- Luzerner Kantonsspital (CH)
- Kantonsspital Baden (CH)
- University Children’s Hospital Basel (CH)
- Institute of Social and Preventive Medicine (CH)
Publication Details
- Journal
- Heart
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1136/heartjnl-2026-328132
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Swiss Cancer Research Foundation